Healthcare
A Breakthrough in Knee Osteoarthritis: Enlivex Reports Promising Six-Month Results for Allocetra
Sustained pain reduction, improved mobility, and strong safety profile position Allocetra™ as a potential game-changer for aging patients Enlivex Therapeutics...
Eli Lilly and Novo Nordisk Strike Weight-Loss Drug Deal with Trump Administration
Landmark agreement cuts drug prices, expands Medicare access, and grants tariff relief to leading obesity drugmakers Eli Lilly & Co....
Pfizer, Novo Nordisk Eye Metsera; Sarepta Sinks, Hertz Surges
Tuesday’s trading session saw major pharmaceutical deals, biotech setbacks, and a surprise comeback in the car rental sector. On Tuesday’s...
Kimberly-Clark and Kenvue Unite to Form Consumer Health Giant
Kimberly-Clark, the maker of household staples like Kleenex and Huggies, has announced plans to acquire Tylenol producer Kenvue in a...
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
Study in eBioMedicine shows strong disease control and survival benefits across multiple tumor types with minimal toxicity Intensity Therapeutics (INTS),...
Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240
Achievement validates CAPTN-3 platform scalability and advances IM1240 toward first-in-human clinical trials in 2026 Purple Biotech (PPBT), a clinical-stage biotechnology...
Co-Diagnostics Expands Global Reach with New Saudi Joint Venture
CoMira Diagnostics to Localize PCR Manufacturing and Healthcare Innovation Across KSA and 18 MENA Countries Co-Diagnostics (CODX), a leading molecular...
Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology
Collaboration aims to enhance transparency, efficiency, and patient safety through smart contract integration Datavault AI (DVLT), a leader in AI-powered...
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
Replimune Reports Promising New Data for Acral Melanoma Treatment at ESMO 2025
RP1 combined with nivolumab shows meaningful tumor response in rare and aggressive skin cancer Replimune Group (REPL), a clinical-stage biotechnology...
